Isoray To Announce Fourth Quarter and Fiscal Year End 2020 Financial Results on September 17, 2020
September 10 2020 - 8:13AM
Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and
innovator in seed brachytherapy, today announced that it will host
a conference call to discuss its financial results for the fourth
quarter and fiscal year ended June 30, 2020 on Thursday, September
17, 2020, at 4:30 p.m. Eastern Time. The Company will issue a press
release announcing its financial results for the fourth quarter and
fiscal year ended June 30, 2020 after the close of the U.S. stock
markets on September 17, 2020.
To listen to the conference call, please dial
(844) 602-0380. For callers outside the U.S., please dial (862)
298-0970.
The conference call will be simultaneously
webcast and can be accessed
at https://www.webcaster4.com/Webcast/Page/2199/37318 by
clicking on the link. The webcast will be available until September
17, 2021 following the conference call.
About IsorayIsoray, Inc., through its
subsidiary, Isoray Medical, Inc. is the sole producer of Cesium-131
brachytherapy seeds, which are expanding brachytherapy options
throughout the body. Learn more about this innovative Richland,
Washington company and explore the many benefits and uses of
Cesium-131, commercially known as Cesium Blu, by visiting
www.isoray.com. Follow us on LinkedIn and Twitter. Join us on
Facebook.
Contact
Investor Relations: Mark Levin (501) 255-1910
Media and Public Relations: Sharon Schultz (302) 539-3747
IsoRay (AMEX:ISR)
Historical Stock Chart
From Jun 2024 to Jul 2024
IsoRay (AMEX:ISR)
Historical Stock Chart
From Jul 2023 to Jul 2024